June 16 (Reuters) - The U.S. Food and Drug Administration issued 25 warning letters to telehealth companies for marketing ...

Tirzepatide is a dual GLP-1 and GIP receptor agonist that mimics two hormones in the gut that help regulate blood sugar, ...

GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably heard of them under brand names like Ozempi c® and Wegovy® (semaglutide) ...

Mon, February 10, 2025 at 4:52 AM UTC Some call these medications “generic Ozempic” (they’re not); others, “fake Ozempic” (nope, except when the ads are for illegal or nonexistent drugs). And last ...

Compounded medications currently represent an estimated 1% to 3% of all prescriptions written in the United States, according ...

Add Yahoo as a preferred source to see more of our stories on Google. Compounded GLP-1 drugs aren't FDA-approved and may carry unknown safety risks. Experts warn of inconsistent quality, dosing and ...

Add Yahoo as a preferred source to see more of our stories on Google. Many Americans have turned to compounding pharmacies to get popular weight-loss drugs due to lack of availability or expensive ...

As the contentious debate over compounded weight loss drugs continues, Eli Lilly is stepping out with an ad campaign to further stake its claim as a leader in the obesity market. In the national print ...

Compounded semaglutide is semaglutide that a person has chemically altered or mixed with one or more other drugs. The Food and Drug Administration (FDA) does not approve the safety or effectiveness of ...

After receiving her degree from the University of California San Diego School of Medicine, Dr. Youdim completed her residency ...

That's where compounding comes in. On this episode of The Vet Blast Podcast presented by dvm360 and recorded live at Fetch ...